18 May 2013
Keywords: gsk, flu, vacc, protects, trial, subjects, uk
Article | 26 July 2006
UK drug major GlaxoSmithKline has reported headline data showing that its H5N1 pandemic flu vaccine achieved a high immune ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 July 2006
24 July 2006
17 May 2013
© 2013 thepharmaletter.com